Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

AMG-3969

SKU: orb1296239

Description

AMG-3969 is a potent small molecule disruptor of the glucokinase-glucokinase regulatory protein (GK-GKRP) interaction, exhibiting an IC50 of 4 nM. This tool compound is valuable for diabetes research, enabling the study of hepatic glucose metabolism in both cellular and animal models to explore potential therapeutic strategies.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number1361224-53-4
MW522.46
Purity99.65% (May vary between batches)
FormulaC21H20F6N4O3S
SMILESCC#C[C@H]1CN(CCN1c1ccc(cc1)C(O)(C(F)(F)F)C(F)(F)F)S(=O)(=O)c1ccc(N)nc1
TargetGlucokinase
SolubilityDMSO:100 mg/mL (191.4 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.66 mM)

Bioactivity

Target IC50
GK-GKRP:4 nM (cell free)
In Vivo
AMG-3969, at a dosage of 100 mg/kg, significantly lowers blood glucose levels, achieving a 56% reduction eight hours post-administration . This compound effectively normalizes blood glucose levels across various rodent diabetes models and exhibits favorable in vivo pharmacokinetic properties in rats (75%). It also progressively reduces blood glucose levels in db/db mice in a dose-responsive manner . Demonstrating efficacy across three diabetes models—diet-induced obese (DIO), ob/ob, and db/db mice, AMG-3969, however, does not impact blood glucose in normoglycemic C57BL/6 (B6) mice. Additionally, it is highly efficient in enhancing carbohydrate metabolism, leading to noticeable prolonged effects on carbohydrate oxidation, evident from the increased respiratory exchange ratio observed up to the following day post a single administration .
In Vitro
AMG-3969 demonstrates significant cellular activity (EC50: 0.202 μM; IC50: 4 nM) [1,2], reversing GKRP's inhibitory effect on GK activity and promoting GK translocation in vitro (isolated hepatocytes) .
Animal Research
Diabetic db/db mice are used in the study. At 8:00 AM, mice are bled via retro-orbital sinus puncture and blood glucose values are determined and used to randomize the animals in which their averages are similar, and only mice with blood glucose ranges between 300 and 500 mg/dL are included. Vehicle (2% hydroxypropyl methylcellulose, 1% Tween 80, pH 2.2 adjusted with MSA) or AMG-3969 (10, 30, 100 mg/kg) are gavaged at 9:00 AM. Blood glucose is measured at 4, 6, or 8 h posttreatment. At each time point, a 15 μL sample of whole blood is analyzed for drug exposure .

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Glucokinase, GK-GKRP, Hexokinase D, Hexokinase IV, Inhibitor, inhibit, AMG 3969, AMG3969, AMG-3969

Similar Products

  • AMG-3969 [orb1218893]

    >98% (HPLC)

    1361224-53-4

    522.46

    C21H20F6N4O3S

    10 mg, 25 mg, 50 mg, 100 mg, 5 mg, 200 mg, 1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 90.00
5 mg
$ 160.00
1 ml x 10 mM (in DMSO)
$ 180.00
10 mg
$ 240.00
25 mg
$ 360.00
50 mg
$ 490.00
100 mg
$ 640.00
200 mg
$ 870.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry